Patient with confirmed LEOPARD syndrome developing multiple melanoma
- PMID: 29445579
- PMCID: PMC5808376
- DOI: 10.5826/dpc.0801a14
Patient with confirmed LEOPARD syndrome developing multiple melanoma
Abstract
LEOPARD syndrome, also known as Gorlin syndrome II, cardiocutaneous syndrome, lentiginosis profusa syndrome, Moynahan syndrome, was more recently coined as Noonan syndrome with multiple lentigines (NSML), inside the RASopathies. Historically, the acronym LEOPARD refers to the presence of distinctive clinical features such as: lentigines (L), electrocardiographic/conduction abnormalities (E), ocular hypertelorism (O), pulmonary stenosis (P), genital abnormalities (A), retardation of growth (R), and sensorineural deafness (D). This condition is identified in 85% of patients with phenotype hallmarks caused by presence a germline point mutation in PTPN11 gene. Association of melanoma to NSML seems to be rare: to our knowledge, two patients so far were reported in the literature. We herein present a patient diagnosed with LEOPARD syndrome, in whom molecular investigation confirmed the presence of the c.1403C>T mutation in exon 12 of the PTPN11 gene, who developed four superficial spreading melanomas and three atypical lentiginous hyperplasias. Three of the melanomas were achromic or hypochromic, three were in situ, and one had a Breslow index under 0.5 mm. Dermoscopic examination showed some characteristic white structures in most of the lesions, which were a signature pattern and a key for the diagnosis.
Keywords: LEOPARD syndrome; dermoscopy; melanomas.
Conflict of interest statement
Competing interests: The authors have no conflicts of interest to disclose.
Figures



References
-
- Gaudy-Marqueste C, Perchenet AS, Taséi AM, et al. The “spaghetti technique”: an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma) J Am Acad Dermatol. 2011;64(1):113–118. - PubMed
-
- Swetter SM, Chen FW, Kim DD, Egbert BM. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type. J Am Acad Dermatol. 2015;72(6):1047–1053. - PubMed
-
- Seishima M, Mizutani Y, Shibuya Y, et al. Malignant melanoma in a woman with LEOPARD syndrome: identification of a germline PTPN11 mutation and a somatic BRAF mutation. Br J Dermatol. 2007;157:1297–1299. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous